Biohit Oyj operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biohit Oyj with three other
pharmaceutical manufacturers in Europe:
sales of 17.69 million Bulgarian Lev [US$9.78 million]
Biotec Pharmacon ASA
(71.90 million Norwegian Kroner [US$8.49 million]
based in France
(9.10 million Euro [US$9.84 million]
Biohit Oyj reported sales of 8.20 million Euro (US$8.86 million)
December of 2016.
increase of 35.5%
versus 2015, when the company's sales were 6.05 million Euro.
This was the fourth straight year of sales growth at Biohit Oyj.